Horizon Urges Dismissal of Bellwether Complaints in Tepezza Hearing Loss MDL



DOCUMENTS
  • Reply


CHICAGO — Horizon Therapeutics USA Inc. is urging an Illinois federal judge to dismiss nine bellwether complaints in the Tepezza hearing loss MDL, arguing that plaintiffs failed to identify any “newly acquired information” that would have allowed it to unilaterally change the drug’s label under the Changes Being Effected regulation.

In a Sept. 27 reply filed before Judge Thomas Durkin of the U.S. District Court for the Northern District of Illinois, Horizon contends that the studies and adverse event reports cited by plaintiffs do not reveal any new information concerning the incidence rate of hearing loss caused by the thyroid …






UPCOMING CONFERENCES




HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference

January 10, 2025 - Long Beach, CA
The Westin Long Beach

MORE DETAILS



HarrisMartin's MDL Conference

December 04, 2024 - New York, NY
Virgin Hotels NYC

MORE DETAILS